Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Chao

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
Journal of Orthopaedic Surgery and Research|July 16, 2025
Biomechanical evaluation of In-Out-In pedicle screws for atlantoaxial posterior fixation in the presence of high-riding vertebral artery and narrow C2 pedicles: a finite element analysisXiong-Han Lian, Wen He, Wen-Jia Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancerSi-Yang Liu, Zhong-Yi Dong, Si-Pei Wu, et al.
Frontiers in Oncology|December 28, 2020
Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung CancerJin Kang, Xu-Chao Zhang, Hua-Jun Chen, et al.
Nature Communications|April 18, 2019
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patientsXu-Chao Zhang, Jun Wang, Guo-Guang Shao, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastasesKai Yin, Yang-Si Li, Mei-Mei Zheng, et al.
Clinical Lung Cancer|May 5, 2010
Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma componentWen-Zhao Zhong, Yi-Long Wu, Xue-Ning Yang, et al.
Oncotarget|June 5, 2016
The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancerLan-Ying Gou, An-Na Li, Jin-Ji Yang, et al.
Clinical Lung Cancer|December 25, 2024
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System DiseaseChang Lu, Hong-Hong Yan, Chan-Yuan Zhang, et al.
Lung Cancer (Auckland, N.Z.)|May 14, 2026
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based <i>MET</i> Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung CancerSi-Yang Maggie Liu, Zhi Xie, Lixu Yan, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathwayXin Yang, Lei Liang, Xiao-Fei Zhang, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
Journal of Orthopaedic Surgery and Research|July 16, 2025
Biomechanical evaluation of In-Out-In pedicle screws for atlantoaxial posterior fixation in the presence of high-riding vertebral artery and narrow C2 pedicles: a finite element analysisXiong-Han Lian, Wen He, Wen-Jia Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancerSi-Yang Liu, Zhong-Yi Dong, Si-Pei Wu, et al.
Frontiers in Oncology|December 28, 2020
Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung CancerJin Kang, Xu-Chao Zhang, Hua-Jun Chen, et al.
Nature Communications|April 18, 2019
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patientsXu-Chao Zhang, Jun Wang, Guo-Guang Shao, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastasesKai Yin, Yang-Si Li, Mei-Mei Zheng, et al.
Clinical Lung Cancer|May 5, 2010
Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma componentWen-Zhao Zhong, Yi-Long Wu, Xue-Ning Yang, et al.
Oncotarget|June 5, 2016
The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancerLan-Ying Gou, An-Na Li, Jin-Ji Yang, et al.
Clinical Lung Cancer|December 25, 2024
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System DiseaseChang Lu, Hong-Hong Yan, Chan-Yuan Zhang, et al.
Lung Cancer (Auckland, N.Z.)|May 14, 2026
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based <i>MET</i> Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung CancerSi-Yang Maggie Liu, Zhi Xie, Lixu Yan, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathwayXin Yang, Lei Liang, Xiao-Fei Zhang, et al.
Pageof 29